Market Overview

DaVita, Fresenius Medical Care Announce Partnership

Related DVA
Earnings Scheduled For February 16, 2017
Barron's Picks And Pans: Goodyear, Johnson & Johnson And More
Related FMS
4 Stocks With Strong Technical Momentum
Akorn Shares Keep Moving Higher As Acquisition Rumored To Be 'Imminent'

DaVita®, the kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced an agreement to provide certain pharmacy services to Fresenius Medical Care (FMC).

FMC, a leading provider of dialysis services and maker of dialysis products, will use DaVita Rx® prescription drug services for its Medicare patients in the United States.

Congress required that beginning in 2011, some oral medications will be included in the bundled payment model. By 2016 all oral end stage renal disease medications will be included in the bundled payment. FMC's contract with DaVita Rx will help implement that requirement by using DaVita Rx's state-of–the-art pharmacy to fill and ship oral medications to FMC Medicare patients. DaVita Rx service for FMC will begin in late 2013.

Posted-In: News Contracts


Related Articles (DVA + FMS)

View Comments and Join the Discussion!